Q32 Bio Inc Net Income per Employee (QTTB), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 


Q32 Bio Inc   (NASDAQ: QTTB)
 

Q32 Bio Inc Net Income per Employee

QTTB's Quarterly Results, Trends, Rankings, Statistics
Q32 Bio Inc 's Income per employee fell in the third quarter 2026 on a trailing twelve month basis to $ 1,343,875, but the productivity of Q32 Bio Inc 's 24 employees remained above the company average.
The Healthcare sector has seen employees of 16 other companies achieving higher income per employee. While Q32 Bio Inc 's total ranking has deteriorated compared to the previous quarter from 157 to 158.


What is Income per Employee Ratio?






QTTB Net Income per Employee (Sep 30 2026)
III. Quarter
(Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 1,343,875 1,407,750 1,385,125 1,242,542 -1,754,083
QTTB's Total Ranking # 158 # 157 # 211 # 3201 #
Seq. Net Income Change - - - - -


QTTB Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 17
Healthcare Sector # 20
Overall Market # 158

Net Income per Employee Statistics
High Average Low
$ 1,407,750 $ -2,436,831 $ -5,362,250
(Jun 30 2026)   (Dec 31 2020)







Companies with similar Income per Employee for 12 month ending Sep 30 2026, within Healthcare Sector Income per Employee Income 12 month ending Sep 30 2026Number of Employees Sep 30 2026
Rallybio Corporation  1,915,000.00 $ 26.810  Million 14 
Rigel Pharmaceuticals Inc  1,765,482.76 $ 307.194  Million 174 
Ironwood Pharmaceuticals inc   1,496,260.00 $ 149.626  Million 100 
Exelixis Inc   1,454,396.69 $ 1,668.193  Million 1,147 
Zevra Therapeutics Inc   1,273,049.18 $ 77.656  Million 61 
Halozyme Therapeutics Inc   1,147,565.01 $ 485.420  Million 423 
Ligand Pharmaceuticals Incorporated  1,094,936.17 $ 51.462  Million 47 
Alnylam Pharmaceuticals Inc   1,089,695.60 $ 2,724.239  Million 2,500 
Nurix Therapeutics Inc   930,211.36 $ 294.877  Million 317 
Krystal Biotech Inc   763,281.36 $ 225.168  Million 295 
Illumina Inc   699,218.75 $ 895.000  Million 1,280 


Date modified: 2026-11-05T10:10:18+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.